Tag: Biohaven Pharmaceutical

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Biohaven Pharmaceutical

Biohaven Pharmaceutical (BHVN) Given a $63.00 Price Target at Oppenheimer

Added to Collection on: 2018-12-18 21:30:00

Tags for this article:

Health
Pharmaceutical industry
Pharmacy
Pharmacology
Medicinal chemistry
Biohaven Pharmaceutical
Biohaven Pharmaceutical Holding Company Ltd.

Click the tags to see associated articles and topics

View Article Details
Biohaven Pharmaceutical (NYSE:BHVN) Upgraded by ValuEngine to Buy

Added to Collection on: 2019-02-13 19:53:41

Tags for this article:

Money
Finance
Stock market
Stock
Financial markets
Corporate finance
Biohaven Pharmaceutical
Biohaven Pharmaceutical Holding Company Ltd.

Click the tags to see associated articles and topics

View Article Details
Biohaven Pharmaceutical's (BHVN) “Hold” Rating Reiterated at Barclays

Added to Collection on: 2019-03-15 22:15:00

Tags for this article:

Money
Finance
Stock market
Stock
Financial markets
Corporate finance
Equity securities
Share
Biohaven Pharmaceutical
Biohaven Pharmaceutical Holding Company Ltd.

Click the tags to see associated articles and topics

View Article Details
The Biohaven Pharmaceutical (BHVN) Given a $65.00 Price Target at Piper Jaffray Companies

Added to Collection on: 2019-05-31 04:54:00

Tags for this article:

Money
Finance
Hedge fund
Economy
Short
Share
Financial regulation
Pharmaceutical industry
Alternative investment management companies
Biohaven Pharmaceutical
Biohaven Pharmaceutical Holding Company Ltd.

Click the tags to see associated articles and topics

View Article Details
Biohaven Pharmaceutical (NYSE:BHVN) Price Target Raised to $76.00 at Morgan Stanley

Added to Collection on: 2021-04-19 14:26:15

Tags for this article:

Financial markets
Finance
Financial economics
Stock market
Equity securities
Price?earnings ratio
Short
Stock
Share
Biohaven Pharmaceutical

Click the tags to see associated articles and topics

View Article Details
Absci Stock Forecast, Price & News

Added to Collection on: 2021-07-23 23:10:42

Tags for this article:

Stada Arzneimittel
Evotec
Acceleron Pharma
Companies
Canopy Growth
Pharmaceutical companies
Health care
Globus Medical
Encompass Health
Tandem Diabetes Care
STADA ARZNEIMITTEL Aktiengesellschaft
Biohaven Pharmaceutical
Tenet Healthcare
Mirati Therapeutics
STAAR Surgical
Beam Therapeutics
Chemed
AbSci

Click the tags to see associated articles and topics

View Article Details
Biohaven Partners with Pfizer to Market Migraine Drug | BioSpace

Added to Collection on: 2021-11-09 21:53:29

Tags for this article:

Calcitonin gene-related peptide receptor antagonists
Migraine
Chemical compounds
Branches of biology
Organic compounds
Rimegepant
Calcitonin gene-related peptide
Pfizer
Headache
CALCRL
Biohaven Pharmaceutical

Click the tags to see associated articles and topics

View Article Details
Is This a Smart Deal for Pfizer? | The Motley Fool

Added to Collection on: 2022-01-29 22:08:00

Tags for this article:

Life Sciences
Health sciences
Health care
Pfizer
Clinical trials
Migraine
Rimegepant
Calcitonin gene-related peptide receptor antagonist
Pharmaceutical industry
Headache
Biohaven Pharmaceutical
United States
PFIZER'S

Click the tags to see associated articles and topics

View Article Details
Pfizer to spend $11.6B on migraine treatment maker Biohaven - Detroit News

Added to Collection on: 2022-05-10 17:49:39

Tags for this article:

Health sciences
Life Sciences
Health care
Pfizer
Clinical trials
BioNTech
Rimegepant
Pharmaceutical industry
Migraine
Pneumococcal conjugate vaccine
Pfizer Inc.
Biohaven Pharmaceutical Holding Company Ltd.
Biohaven Pharmaceutical

Click the tags to see associated articles and topics

View Article Details
Pfizer's Acquisition of Biohaven Pharmaceutical - Global Legal Chronicle

Added to Collection on: 2022-05-12 10:34:01

Tags for this article:

Law firms
Chemical compounds
Organic compounds
Ropes & Gray
Pfizer
SKADDEN, ARPS, SLATE, MEAGHER & FLOM
Centerview Partners
Rimegepant
Calcitonin gene-related peptide receptor antagonist
Ropes
Pfizer Inc.
Biohaven Pharmaceutical
Skadden

Click the tags to see associated articles and topics

View Article Details